Less Ads, More Data, More Tools Register for FREE

Director/PDMR Shareholding

29 Mar 2011 15:19

RNS Number : 8438D
Allergy Therapeutics PLC
29 March 2011
 



29 March 2011

 

Allergy Therapeutics plc

("Allergy Therapeutics" or "the Company")

 

Director/PDMR Shareholding

 

 

Allergy Therapeutics plc (AIM: AGY), the fully integrated speciality pharmaceutical company specialising in allergy vaccines, was informed on 29th March 2011 that Dr Virinder Nohria, a non-executive director, purchased 50,000 Ordinary Shares of 0.1p each ('Ordinary Shares') on 29th March 2011 at a price of 8.6p per Ordinary Share.

 

Following this share purchase Dr Nohria holds 512,160 Ordinary Shares representing 0.16 per cent. of the issued share capital of the Company.

 

 

For further information

 

Allergy Therapeutics

+44 (0) 1903 845 820

Manuel Llobet, Chief Executive Officer

Ian Postlethwaite, Finance Director

www.allergytherapeutics.com

Nomura Code Securities

+44 (0) 207 776 1200

Juliet Thompson/ Clare Terlouw

Financial Dynamics

+44 (0) 207 831 3113

Ben Brewerton/ Susan Quigley

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBSGDXCBDBGBC

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS